Over a decade has passed since we acquired the Epinephrine (Adrenaline) business from Boehringer Ingelheim. At Transo-Pharm, we didn’t just take over the business — we made a commitment to ensuring a secure supply chain for our customers. We've gone even further by integrating upstream to become less dependent on external suppliers for starting materials. Throughout the transition, we consistently provided bridging stock on time and streamlined the regulatory process for our valued partners.

​Discover the incredible journey we've been on...

Dear Customers,
 
On May 25th we informed you about the fire accident at our Contract Manufacturer Syn-Tech in Taiwan.
 
We are happy to inform you that the next production campaign for Epinephrine and Epinephrine bitartrate started – only 3 weeks after the incident.
 
Thanks to the Syn-Tech colleagues for this tremendeous effort and excellent support during these difficult weeks.
 
Needless to say, there are no delays in deliveries as we are still supplying the API’s from our stock in Hamburg/Germany.

Dear Customers,
 
We regret to inform you that Syn-Tech Chem. & Pharm., Co Ltd. had a fire accident on May 20, 2021. Fortunately, nobody of the employees or the firefighters were injured.
 
The production facility where Epinephrine and Epinephrine bitartrate are produced are not affected at all.
​The same applies to raw & starting material warehouse, finished product warehouse and QA/QC labs. Nevertheless, a detailed review and investigation is currently underway.
 
Due to our extensive stockpiling program at our German site, Transo-Pharm can easely compensate such an event and can continue the supply of both API’s according to the existing demands and forecasts.
 
Please be assured that we continuously keep you updated on the status at our partner in Taiwan.

2. Update: Given the current Coronavirus (SARS-CoV-2) development it is reassuring that we can continue to ensure stable supply of both products. We have sufficient inventory in our German warehouse.

1. Update: Please find now coronavirus statement issued by Syn-Tech, Taiwan below attached.

As the coronavirus continues to spread in China, the Chinese Government extended the New Year holiday one additional week to February 9th. Some API factories may not re-open until the 16th to help contain the spread of the virus.
API shortages will be expected due to the extension of Chinese New Year.  
 
Transo-Pharm has a significant stock of Epinephrine Base and Bitartrate manufactured by Syn-Tech (Taiwan) available to our global customers.
 
Transo-Pharm does not expect any shortages in supply due to the coronavirus.

Coronavirus outbreak in China may disrupt global drug supply chains  - but not at Transo-Pharm !

We at Transo-Pharm assure always continuous supply of API Phenylephrine HCl from our CMO, Hisoar, China.
The Coronavirus has no negative impact on our supply chain.

Due to extended stocks Transo-Pharm is able to supply the markets from their warehouse in Germany without any disruption. The next production campaign of the API will start earlier in order to have more time for production, release and the transport out of China.  A continuous supply of API for the global customers is guaranteed.

Please find our update here